✦ LIBER ✦

Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma

✍ Scribed by Ornstein, D.K.; Finley, D.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II placebo-controlled randomized d

✍ Paul Russo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 36 KB

A Phase II Trial of Intrapatient Dose-Es

✍ Robert Amato; Jim Zhai; James Willis; Somyata Saxena; Melissa DeFoe 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 705 KB

Randomized Phase II Trial of First-Line

✍ Coplen, D.E. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 69 KB

Phase II Trial of Suramin in Patients wi

✍ Robert Dreicer; David C. Smith; Richard D. Williams; William A. See 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 43 KB

Phase II Trial of Arsenic Trioxide in Pa

✍ Jacqueline Vuky; Richard Yu; Lawrence Schwartz; Robert J. Motzer 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 55 KB

719 EVEROLIMUS IN PATIENTS WITH METASTAT

✍ S. Oudard; B. Escudier; T. Hutson; C. Porta; S. Bracarda; V. Grunwald; J. Thomps 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 194 KB